Ovarian Epithelial Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]
Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallop…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating irofulven in recurrent or persistent ovarian epithelial cancer and primary peritoneal cancer; study comple…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallop…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bortezomib in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update of temsirolimus in refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer; results po…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing tamoxifen to thalidomide in women with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride in combination with tanespimycin for recurrent advanced ovarian epithelial cancer or prim…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer [Phase 2]
A National Cancer Institute-sponsored Phase 2 trial of romidepsin (depsipeptide) for recurrent ovarian epithelial cancer and primary periton…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors [NA]
A completed clinical trial evaluated pelvic floor muscle training for urinary incontinence in survivors of gynecologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A phase 2 clinical trial evaluating imatinib mesylate for persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating paclitaxel, cisplatin, and topotecan with or without filgrastim in newly diagnosed stage III or stage IV epithelial…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
This entry reports the completion status of a Phase 2 trial evaluating interleukin-12 in patients with ovarian epithelial cancer or primary …
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]
This NCI-sponsored clinical trial evaluating EF5 and Motexafin Lutetium for detecting tumor cells in patients with abdominal cancers or non-…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and N…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer [Phase 1, Phase 2]
The document reports a completed Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody in combination with peripheral stem …
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer [Phase 2]
Phase 2 clinical trial of CerviPrep delivering topical gemcitabine to the cervix for primary cervical, endometrial, or ovarian epithelial ca…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial evaluating fulvestrant for recurrent ovarian epithelial cancer has completed with results posted in 2010.